Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 62.74 | 35.48 | 26.80 | 6.07 | - |
Total Expenses | 60.25 | 34.35 | 26.51 | 5.91 | - |
Profit Before Tax | 2.49 | 1.11 | 0.27 | 0.16 | - |
Profit After Tax | 1.95 | 0.81 | 0.36 | 0.15 | - |
Operating Profit after Depreciation | 3.16 | 1.92 | 0.77 | 0.34 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 10.20 | 10.13 | 2.01 | 1.70 | - |
Total Non Current Assets | 12.53 | 10.71 | 9.27 | 3.22 | - |
Total Current Assets | 24.63 | 23.59 | 18.82 | 14.78 | - |
TOTAL ASSETS | 37.17 | 34.30 | 28.09 | 18 | - |
Total Shareholder's Fund | 14.18 | 11.72 | 10.99 | 4.78 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 5.35 | 1.10 | -1.08 | -0.31 | - |
Net Cash used in Investing Activities | -3.61 | -3.44 | -6.14 | -2.02 | - |
Net Cash used in Financing Activities | -1.77 | 2.42 | 6.71 | 2.95 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 51.44 | 28.97 | 26.80 | 6.07 | 1.43 |
Total Expenses | 49.96 | 28.51 | 26.45 | 5.91 | 1.12 |
Profit Before Tax | 1.48 | 0.46 | 0.34 | 0.16 | 0.30 |
Profit After Tax | 1.11 | 0.29 | 0.42 | 0.15 | 0.23 |
Operating Profit after Depreciation | 1.69 | 0.80 | 0.83 | 0.34 | 0.35 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 1.48 | 0.83 | 0.94 | 1.07 | 1.15 |
Total Non Current Assets | 6.37 | 5.69 | 6.45 | 1.96 | 1.41 |
Total Current Assets | 17.12 | 16.17 | 16.91 | 13.73 | 13.14 |
TOTAL ASSETS | 23.49 | 21.86 | 23.36 | 15.69 | 14.54 |
Total Shareholder's Fund | 13.33 | 11.32 | 11.03 | 4.78 | 3.23 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 3.13 | 1.09 | -0.32 | 1.38 | 0.40 |
Net Cash used in Investing Activities | -0.88 | 0.46 | -4.58 | -0.70 | - |
Net Cash used in Financing Activities | -2.18 | -1.52 | 4.27 | -0.06 | -0.24 |
No data available
No data available
No data available
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Walpar Nutritions Ltd | ₹49.75 | ₹46.72 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
12 Nov 2024, 10:28 am
06 Jul 2024, 05:33 pm
02 Jul 2024, 02:20 pm
24 May 2024, 01:46 pm
06 Nov 2023, 12:03 pm